We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
27
2 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
2003
Active, not recruiting
2
7.4%
Completed
16
59.3%
Recruiting
1
3.7%
Terminated
4
14.8%
Unknown
3
11.1%
Withdrawn
No approval data available
- ImmunityBio has agreed to a revised lease with New York State for the Dunkirk pharmaceutical facility, increasing annual rent from $1 to $525,000 and committing to $40 million in capital improvements. - The company must hire at least 100 employees by the end of 2028 and scale to 450 employees by 2032, representing a more realistic timeline compared to the failed Athenex agreement. - The new one-year renewable lease structure allows annual compliance assessments, with stricter accountability measures following nearly a decade of uncertainty at the state-funded facility.
